Hopkinson Craig C.
- SEC CIK
- 0001730048
In the past year, 14 open-market sale filings worth $3.94M and no purchases.
Current role at each company
- ALKS Alkermes plc.EVP R&D, Chief Medical Officeras of Sep 1, 2026
- ALBO Albireo Pharma, Inc.Directoras of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.94M
- 14 filings
- Net
- −$3.94M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hopkinson Craig C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALKS Alkermes plc.
EVP R&D, Chief Medical Officer23 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 (view filing) | Feb 18 | 5 days | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −2.31K | $25.17 | −$58.0K | −19.5%9.50K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −12.0K | $24.76 | −$296.7K | −40.0%18.0K after | |
| Nov 6, 2024 (view filing) | Nov 6 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −10.5K | $29.53 | −$309.2K | −9.5%99.2K after | 10b5-1 |
| Nov 12, 2024 (view filing) | Nov 11 | 1 day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −59.0K | $30.08 | −$1.77M | −41.5%83.3K after | 10b5-1 |
| Dec 4, 2024 (view filing) | Dec 4 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −14.3K | $30.77 | −$441.5K | −17.2%69.0K after | 10b5-1 |
| Dec 5, 2024 (view filing) | Dec 5 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.22K | $31.50 | −$290.5K | −13.4%59.7K after | 10b5-1 |
| Dec 9, 2024 (view filing) | Dec 9 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −61.2K | $32.07 | −$1.96M | −56.2%47.6K after | 10b5-1 |
| Jan 31, 2025 (view filing) | Jan 30 | 1 day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −100.9K | $32.05 | −$3.23M | −69.5%44.3K after | 10b5-1 |
| Feb 14, 2025 (view filing) | Feb 12-13 | 2 days | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −349.3K | $33.92 | −$11.8M | −85.8%57.9K after | 4 lots10b5-1 |
| Oct 15, 2025 (view filing) | Oct 15 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $31.53 | −$283.8K | −10.9%73.7K after | 10b5-1 |